Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is race an independent prognostic factor for survival from prostate cancer?

× No keyword cloud information.

50 in total

1. Evidence of an X-linked or recessive genetic component to prostate cancer risk.

Authors: K R Monroe; M C Yu; L N Kolonel; G A Coetzee; L R Wilkens; R K Ross; B E Henderson
Journal: Nat Med Date: 1995-08 Impact factor: 53.440

2. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Authors: J K Reichardt; N Makridakis; B E Henderson; M C Yu; M C Pike; R K Ross
Journal: Cancer Res Date: 1995-09-15 Impact factor: 12.701

3. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

Authors: M M Braun; K J Helzlsouer; B W Hollis; G W Comstock
Journal: Cancer Causes Control Date: 1995-05 Impact factor: 2.506

4. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men.

Authors: E H Corder; G D Friedman; J H Vogelman; N Orentreich
Journal: Cancer Epidemiol Biomarkers Prev Date: 1995-09 Impact factor: 4.254

5. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample.

Authors: R A Hiatt; J D Ordoñez
Journal: Cancer Epidemiol Biomarkers Prev Date: 1994 Jul-Aug Impact factor: 4.254

6. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.

Authors: K J Pienta; R Demers; M Hoff; T Y Kau; J E Montie; R K Severson
Journal: Urology Date: 1995-01 Impact factor: 2.649

7. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening.

Authors: W Demark-Wahnefried; T Strigo; K Catoe; M Conaway; M Brunetti; B K Rimer; C N Robertson
Journal: Urology Date: 1995-09 Impact factor: 2.649

Review 8. The prognostic significance of race and survival from breast cancer: a model for assessing the reliability of reported survival differences.

Authors: M Roach; M Alexander
Journal: J Natl Med Assoc Date: 1995-03 Impact factor: 1.798

9. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.

Authors: N J Vogelzang; G W Chodak; M S Soloway; N L Block; P F Schellhammer; J A Smith; R J Caplan; G T Kennealey
Journal: Urology Date: 1995-08 Impact factor: 2.649

10. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy.

Authors: J A Kim; D A Kuban; A M el-Mahdi; P F Schellhammer
Journal: Radiology Date: 1995-02 Impact factor: 11.105